Visceral leishmaniasis and hemophagocytic lymphohistiocytosis: A case report;Viscerale leishmaniasis met hemofagocytaire lymfohistiocytose: Casus en literatuuroverzicht

Tijdschrift voor Geneeskunde

Volumn 65, Issue 12, 2009, Pages 570-574

  Wallemacq, P ^a,d   Van Esbroeck, M ^b   Thomeer, M ^c   Dierickx, D ^a   Vanderschueren, S ^a   Van Wijngaerden, E ^a  

^a UZ Leuven Campus Gasthuisberg ^*  (Belgium)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^c DEPARTMENT OF CARDIOLOGY   (Belgium)

^d SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; AZITHROMYCIN; C REACTIVE PROTEIN; CYCLOSPORIN; DEXAMETHASONE; DOXYCYCLINE; ETOPOSIDE; ISONIAZID; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ARTICLE; ASPERGILLOSIS; BARTONELLA; BRUCELLA; CASE REPORT; CELL PROLIFERATION; CLINICAL ASSESSMENT; CLINICAL FEATURE; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; FATALITY; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HISTIOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOCOMPROMISED PATIENT; INTENSIVE CARE; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LEISHMANIA; LISTERIA; MYCOBACTERIUM; PARVOVIRUS; POLYMERASE CHAIN REACTION; TOXOPLASMA; TREATMENT OUTCOME; TUBERCULOSIS; VISCERAL LEISHMANIASIS;

EID: 67649867360     PISSN: 0371683X     EISSN: None     Source Type: Journal    
DOI: 10.2143/TVG.65.12.2000564     Document Type: Article

References (23)

1. OZYÜREK E, OZÇAY F, YILMAZ B, OZBEK N. Hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis: a case report. Pediatr Hematol Oncol 2005; 22: 409-414. (Pubitemid 40993604)
2. MAROM D, OFFER I, TAMARY H, JAFFE CL, GARTY BZ. Hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis. Pediatr Hematol Oncol 2001; 18: 65-70. (Pubitemid 32064228)
3. GRANERT C, ELINDER G, OST A, HENTER JI. Kala-azar in a one-year-old Swedish child. Diagnostic difficulties because of active hemophagocytosis. Acta Paediatr 1993; 82: 794-796.
4. DE VOOGHT A, VERHOEF G. Epstein-Barr-virusgerelateerde hemofagocytaire lymfohistiocytose. Patiëntencasus en overzicht van de literatuur. Tijdschr Geneesk 2005; 61: 1622-1625.
5. CESARO S, LOCATELLI F, LANINO E, et al. Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (ATEOP). Hematologica 2008; 93: 1694-1701.
6. MATHUR P, SAMANTARAY JC, SAMANTA P. Fatal haemophagocytic syndrome and hepatitis associated with visceral leishmaniasis. Indian J Med Microbiol 2007; 25: 416-418.
7. HENTER JI, HORNE AC, ARICÓ M, et al. HLH-2004: Diagnostic and therapeutic guidelines for haemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124-131. (Pubitemid 44958267)
8. WEISSER M, KHANLARI B, ARBER C, et al. Visceral leishmaniasis: a threat to immunocompromised patients in non-endemic areas? Clin Microbiol Infect 2007; 13: 751-753.
9. GAGNAIRE MH, GALAMBRUN C, STÉPHAN JL. Hemophagocytic syndrome: A misleading complication of visceral leishmaniasis in children - a series of 12 cases. Pediatrics 2000; 106: E58.
10. DUJARDIN JC, CAMPINO L, CARNAVATE C, et al. Spread of vector-borne disease and neglect of Leishmaniasis. Europe. Emerg Infect Dis 2008; 14: 1013-1018. (Pubitemid 351920428)
11. RAJAGOPALA S, DUTTA U, CHANDRA KS, BHATIA P, VARMA N, KOCHHAR R. Visceral leishmaniasis associated hemophagocytic lymphohistiocytosis-case report and systematic review. J Infect 2008; 56: 381-388.
12. KILANI B, AMMARI L, KANOUN F, CHAABANE B, ABDELLATIF S, CHAKER E. Hemophagocytic syndrome associated with visceral leishmaniasis. Int J Infect Dis 2006; 10: 85-86. (Pubitemid 43003598)
13. KOÇAK N, EREN M, YÜCE A, GÜMRÜK F. Hemophagocytic syndrome associated with visceral leishmaniasis. Indian Pediatr 2004; 41: 605-607. (Pubitemid 38843581)
14. CHAPPUIS F, SUNDAR S, HAILU A, et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 2007; 5: 873-882.
15. TUNÇ B, AYATA A. Hemophagocytic syndrome: a rare life-threatening complication of visceral leishmaniasis in a young boy. Pediatr Hematol Oncol 2001; 18: 531-536. (Pubitemid 33108276)
16. CRÉPUT C, GALICIER L, BUYSE S, AZOULAY E. Understanding organ dysfunction in hemophagocytic lymphohistiocytosis. Intensive Care Med 2008; 34: 1177-1187.
17. DIERICKX D, VANDENBERGHE P, VERHOEF G. Hemofagocytaire lymfohistiocytose. Nederlands Tijdschrift voor Hematologie 2006; 3: 214-220.
18. KONTOPOULOU T, TSAOUSIS G, VAIDAKIS E, et al. Hemophagocytic syndrome in association with visceral leishmaniasis. Am J Med 2002: 113: 439-440. (Pubitemid 35223619)
19. JANKA GE. Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr 2007; 166: 95-109. (Pubitemid 46025500)
20. LEW JW, KOH CK, SELVAN VS, SHEN E. The hunt for an elusive source of pyrexia in a foreign worker. Singapore Med J 2007; 48: e111-e113. (Pubitemid 351235437)
21. SUNDAR S, RAI M, CHAKRAVARTY J, et al. New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine. Clin Infect Dis 2008; 47: 1000-1006.
22. JANKA G, IMASHUKU S, ELINDER G, SCHNEIDER M, HENTER JI. Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 1998; 12: 435-444.
23. FITENI I, PEREZ-LUNGMUS G, GRASA JM, MOTIS C. The hemophagocytic syndrome in an immunocompromised patient: A diagnostic challenge. Can J Infect Dis 2004; 15: 101-103. (Pubitemid 38667762)